French Guiana Wellness Network
SEE OTHER BRANDS

Keeping up with health and wellness news from French Guiana

French Guiana Wellness Network: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on French Guiana Wellness Network.

Press releases published on April 7, 2025

Discolouration Serum Market projected to reach US$4.395 billion by 2030 at a significant CAGR of 6.20%

Discolouration Serum Market projected to reach US$4.395 billion by 2030 at a significant CAGR of 6.20%

The discolouration serum market is anticipated to grow at a CAGR of 6.20% from US$3.254 billion in 2025 to US$4.395 billion by 2030. NEW YORK, NY, UNITED STATES, April 7, 2025 /⁨EINPresswire.com⁩/ -- According to a new study published by Knowledge …

Single Use Bioreactor Market Poised to Growth USD 6.5 Billion by 2035 with Thriving CAGR of 8.36%

Single Use Bioreactor Market Poised to Growth USD 6.5 Billion by 2035 with Thriving CAGR of 8.36%

Rising demand for biologics and personalized medicine is pushing manufacturers toward flexible, scalable solutions. US, NY, UNITED STATES, April 7, 2025 /⁨EINPresswire.com⁩/ -- Single-Use Bioreactor Market Set to Reach USD 6.5 Billion by 2035 Amid Surge …

Longevity Market Poised to Growth USD 63.0 Billion by 2035 with Thriving CAGR of 10.37%

Longevity Market Poised to Growth USD 63.0 Billion by 2035 with Thriving CAGR of 10.37%

The rise of wearables, fitness tracking, and AI-powered health platforms supports this self-quantification trend. US, NY, UNITED STATES, April 7, 2025 /⁨EINPresswire.com⁩/ -- Longevity Market: Reimagining Human Health span and Lifespan Introduction: …

35th Annual National Suicide Prevention Conference in Richmond Hill, Ontario

35th Annual National Suicide Prevention Conference in Richmond Hill, Ontario

RICHMOND HILL, Ontario, April 07, 2025 (GLOBE NEWSWIRE) -- The Canadian Association for Suicide Prevention (CASP) is thrilled to announce the 35th Annual National Suicide Prevention Conference, scheduled to take place May 14 - 16, 2025, at the Sheraton …

Magnetoencephalography Market Expected to Hit USD 1.44 Billion by 2034 with a Remarkable 6.18% CAGR

Magnetoencephalography Market Expected to Hit USD 1.44 Billion by 2034 with a Remarkable 6.18% CAGR

Recent advancements in SQUID (Superconducting Quantum Interference Devices) and optically pumped magnetometers (OPMs) have revolutionized MEG hardware. US, NY, UNITED STATES, April 7, 2025 /⁨EINPresswire.com⁩/ -- Magnetoencephalography Market: Advancing …

Gas Chromatography Market Set to Grow at an Impressive CAGR of 7.01% Through 2034 | USD 15.08 Billion

Gas Chromatography Market Set to Grow at an Impressive CAGR of 7.01% Through 2034 | USD 15.08 Billion

These initiatives underscore the market’s competitive and innovation-driven nature. US, NY, UNITED STATES, April 7, 2025 /⁨EINPresswire.com⁩/ -- Gas Chromatography Market to Reach USD 15.08 Billion by 2034, Driven by Technological Innovation and Rising …

Tanke Biosciences Corp Announces the Appointment of John P. Hopkins Executive Chairman of the Board of Directors

Tanke Biosciences Corp Announces the Appointment of John P. Hopkins Executive Chairman of the Board of Directors

Las Vegas, Nevada, April 07, 2025 (GLOBE NEWSWIRE) -- Tanke Biosciences Corp (the “Company”) (OTC: TNBI) announced today that John P. Hopkins has been appointed Executive Chairman of the Company’s Board of Directors, effective March 31st, 2025. Mr. Hopkins …

Bluejay Diagnostics Announces Entry into Warrant Inducement Transaction for Approximately $3.7 Million in Gross Proceeds

Bluejay Diagnostics Announces Entry into Warrant Inducement Transaction for Approximately $3.7 Million in Gross Proceeds

ACTON, Mass., April 07, 2025 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company”), a medical technology company developing rapid diagnostics on its Symphony platform to improve patient outcomes in critical care settings …

Merit Medical Systems to Announce First Quarter 2025 Results on April 24, 2025

Merit Medical Systems to Announce First Quarter 2025 Results on April 24, 2025

SOUTH JORDAN, Utah, April 07, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, announced today that it will release its financial results for the quarter ended March …

Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

BEDFORD, Mass., April 07, 2025 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global leader in the Osteoarthritis (“OA”) Pain Management and Regenerative Solutions space focused on early intervention orthopedics, today announced that on …

PainReform Provides Year-End Business Update

PainReform Provides Year-End Business Update

TEL AVIV, Israel, April 07, 2025 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX) ("PainReform" or the "Company"), a specialty pharmaceutical company focused on the reformulation of established therapeutics and commercialization of the DeepSolar …

Avicanna Announces Receipt of Management Cease Trade Order and Provides Bi-Weekly Status Update

Avicanna Announces Receipt of Management Cease Trade Order and Provides Bi-Weekly Status Update

Auditor Licensing …

Jeune Aesthetics Appoints Marc Forth as Chief Executive Officer

Jeune Aesthetics Appoints Marc Forth as Chief Executive Officer

PITTSBURGH, April 07, 2025 (GLOBE NEWSWIRE) -- Jeune Aesthetics, Inc. (“Jeune”), a wholly owned subsidiary of Krystal Biotech, Inc. (“Krystal”) (NASDAQ: KRYS) leveraging Krystal’s clinically validated gene-delivery platform to fundamentally address and …

Oragenics, Inc. Participates in the 3rd Nasal Formulation & Delivery Summit

Oragenics, Inc. Participates in the 3rd Nasal Formulation & Delivery Summit

SARASOTA, Fla., April 07, 2025 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a biotechnology company focused on developing novel intranasal therapies for brain-related disorders, today announced that Chief Medical Officer Dr. James Kelly …

Pacira BioSciences Announces Settlement of U.S. Patent Litigation for EXPAREL

Pacira BioSciences Announces Settlement of U.S. Patent Litigation for EXPAREL

-- Fresenius Kabi licensed to sell volume-limited amounts of generic bupivacaine liposome injectable suspension in the U.S. no earlier than a confidential date in 2030 -- -- Fresenius also licensed to sell generic bupivacaine liposome injectable suspension …

CareMed Has Been Selected as a National Specialty Pharmacy Partner for VANRAFIA™ (atrasentan)

CareMed Has Been Selected as a National Specialty Pharmacy Partner for VANRAFIA™ (atrasentan)

NEW HYDE PARK, N.Y., April 07, 2025 (GLOBE NEWSWIRE) -- CareMed, an independent specialty pharmacy, is in the Limited Distribution Network for Vanrafia™ (atrasentan), for the reduction of proteinuria in adults with primary immunoglobulin A nephropathy ( …

Solésence Announces Uplisting to Nasdaq

Solésence Announces Uplisting to Nasdaq

Trading set to begin Tuesday, April 8 under new ticker “SLSN” ROMEOVILLE, Ill., April 07, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (OTCQB: NANX), a leader in scientifically-driven health care solutions across beauty and life science categories, today …

Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2025 Financial Results on May 8, 2025

Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2025 Financial Results on May 8, 2025

CANTON, Mass., April 07, 2025 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and …

Pliant Therapeutics Announces Upcoming Presentations at the 2025 American Thoracic Society International Conference

Pliant Therapeutics Announces Upcoming Presentations at the 2025 American Thoracic Society International Conference

SOUTH SAN FRANCISCO, Calif., April 07, 2025 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX) today announced that the Company will present three scientific posters at the upcoming 2025 American Thoracic Society (ATS) International Conference, …

CVRx Reports Preliminary First Quarter 2025 Financial Results

CVRx Reports Preliminary First Quarter 2025 Financial Results

MINNEAPOLIS, April 07, 2025 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company, today announced certain preliminary unaudited first quarter 2025 revenue results. “While we continue to make significant progress …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service